From 65 to 70 years old: what is the best approach in the treatment of glioblastoma?doi:10.18203/2349-3933.IJAM20214513Joo UlrichDiogo DelgadoAndré FigueiredoMiguel SimasMaria Eduarda NevesJoana PiscoManuel Carmo da SilvaAndré Abrunhosa Branquinho...
Denvax, A leading immunotherapy cancer treatment hospital in India. Enquire about the cost of immunotherapy services in India and other details. Schedule an Appointment Now!
He has special interest in the treatment of brain tumours like Gliomas, Glioblastomas and benign tumours like Meningiomas and Schwannomas. He keeps adding to his skills by attending conferences and publishing articles in various national and international journals. He is also on the editorial board ...
Food and Drug Administration (FDA) in 2010 for the treatment of advanced melanoma.8 PD-1 PD-1 has emerged as a promising target that is capable of inducing antitumor immune responses. In contrast to CTLA-4, it is more broadly expressed and functions to limit the activity of T cells in ...
Diagnosis of inflammation, monitoring of disease evolution and treatment effects require the use of specific biomarkers which can be measured in the clinical context. Biomarkers allow to diagnose both symptomatic and pre-symptomatic diseases, may have a prognostic value and are useful to the follow-up...
Characterization of dysregulated lncRNA-mRNA network based on ceRNA hypothesis to reveal the occurrence and recurrence of myocardial infarction Guangde Zhang Haoran Sun Hongbo Shi ArticleOpen Access21 Feb 2018 Cell Death Discovery Inhibition of glioblastoma cell proliferation, invasion, and mechanism of...
Breaking through the glioblastoma micro-environment via extracellular vesicles Thomas Simon Ellen Jackson Georgios Giamas Review ArticleOpen Access4 May 2020 Oncogene Tumour kinome re-wiring governs resistance to palbociclib in oestrogen receptor positive breast cancers, highlighting new therapeutic modaliti...
The antipsychotic treatment has been at the center of a couple of different controversies that may bring its useful life to even more of a halt. In the early 2000s, the FDA’s office of criminal investigation claimed Eli Lilly was promoting off-label usage of the drug, meaning it ...
A phase 1 study to assess BDTX-1535, an oral EGFR inhibitor, in patients with glioblastoma or non–small-cell lung cancer. TPS9156#Background:The epidermal growth factor receptor (EGFR) is a potent oncogene commonly altered in many cancers, including glioblastoma (GBM) and non-... ML Johnso...
The wide range of venom bioactivity can be seen in these different drugs being utilised in the treatment of coronary syndrome, chronic pain treatment, diabetes, hypertension, and sciatica [1]. Only one of these drugs, Prialt®, comes from a marine organism (Conus magus), which is ...